Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever

被引：7
|
作者：
Inui, Keita [1 ]
Sawa, Naoki [1 ]
Suwabe, Tatsuya [1 ]
Mizuno, Hiroki [1 ]
Yamanouchi, Masayuki [1 ]
Hiramatsu, Rikako [1 ]
Hayami, Noriko [1 ]
Hoshino, Junichi [1 ,2 ]
Kinowaki, Keiichi [3 ]
Fujii, Takeshi [3 ]
Ohashi, Kenichi [3 ]
Ubara, Yoshifumi [1 ,2 ]
机构：
[1] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan
[2] Okinaka Mem Inst Med Res, Tokyo, Japan
[3] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan
来源：
MODERN RHEUMATOLOGY CASE REPORTS | 2020年 / 4卷 / 02期
关键词：
ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY;
D O I：
10.1080/24725625.2020.1739193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：310 / 311
页数：2
相关论文
共 50 条
  • [1] Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever
    Yilmaz, Sedat
    Cinar, Muhammet
    Simsek, Ismail
    Erdem, Hakan
    Pay, Salih
    RHEUMATOLOGY, 2015, 54 (03) : 564 - 565
  • [2] TOCILIZUMAB (TCZ) IN THE TREATMENT OF AA AMYLOIDOSIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
    Ozdogan, H.
    Ugurlu, S.
    Hacioglu, A.
    Adibnia, Y.
    Hamuryudan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 313 - 313
  • [3] Tocilizumab Is Effective in the Treatment of AA Amyloidosis Secondary to Familial Mediterranean Fever
    Ozdogan, Huri
    Ugurlu, Serdal
    Hacioglu, Aysa
    Adibnia, Yasaman
    Hamuryudan, Vedat
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever.
    Ozdogan, Huri
    Ugurlu, Serdal
    Hacioglu, Aysa
    Adibnia, Yasaman
    Hamuryudan, Vedat
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S540 - S541
  • [5] Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
    Serdal Ugurlu
    Aysa Hacioglu
    Yasaman Adibnia
    Vedat Hamuryudan
    Huri Ozdogan
    Orphanet Journal of Rare Diseases, 12
  • [6] Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
    Ugurlu, Serdal
    Hacioglu, Aysa
    Adibnia, Yasaman
    Hamuryudan, Vedat
    Ozdogan, Huri
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [7] Expression of ASC in Renal Tissues of Familial Mediterranean Fever Patients with Amyloidosis: Postulating a Role for ASC in AA Type Amyloid Deposition
    Balci-Peynircioglu, Banu
    Waite, Andrea L.
    Schaner, Philip
    Taskiran, Zihni Ekim
    Richards, Neil
    Orhan, Diclehan
    Gucer, Safak
    Ozen, Seza
    Gumucio, Deborah
    Yilmaz, Engin
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (11) : 1324 - 1333
  • [8] TOCILIZUMAB AS A SUCCESSFUL TREATMENT OF AA-TYPE AMYLOIDOSIS IN A CHILD WITH FAMILIAL MEDITERRANEAN FEVER
    Nassih, Houda
    El Qadiry, Rabiy
    Bourrahouat, Aicha
    Sab, Imane Ait
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3396 - 3396
  • [9] LONG-TERM COLCHICINE THERAPY FOR RENAL AMYLOIDOSIS IN FAMILIAL MEDITERRANEAN FEVER
    WALKER, F
    BEAR, RA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1982, 127 (12) : 1163 - 1164
  • [10] TOCILIZUMAB IN THE TREATMENT OF PATIENTS WITH AA AMYLOIDOSIS SECONDARY TO FAMILIAL MEDITERRANEAN FEVER: CASE SERIES
    Yilmaz, S.
    Cinar, M.
    Simsek, I.
    Erdem, H.
    Pay, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 312 - 313
12345